Aberdeen Group Plc (SLFPY)

Verve Therapeutics Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,604	1,321	1,196	1,133	1,904	1,519
Cash & Short-Term Investments	1,604	1,321	1,196	1,133	1,904	1,519
Cash Growth	14.82%	10.45%	5.56%	-40.49%	25.35%	-6.87%
Accounts Receivable	-	480	451	468	428	360
Other Receivables	1,673	394	487	324	115	9
Receivables	1,673	874	938	792	543	369
Prepaid Expenses	-	47	52	46	44	40
Restricted Cash	-	12	19	14	26	28
Other Current Assets	3,012	765	771	1,186	1,541	1,604
Total Current Assets	6,289	3,019	2,976	3,171	4,058	3,560
Property, Plant & Equipment	116	135	163	201	187	236
Long-Term Investments	1,816	1,969	2,233	3,067	4,576	4,463
Goodwill	881	908	912	935	331	85
Other Intangible Assets	444	507	618	579	269	367
Long-Term Deferred Tax Assets	185	197	215	212	168	131
Long-Term Deferred Charges	55	59	48	106	107	53
Other Long-Term Assets	1,783	927	866	941	1,722	1,583
Total Assets	11,569	7,721	8,031	9,212	11,418	10,478
Accounts Payable	-	-	-	-	5	6
Accrued Expenses	-	234	284	326	377	408
Short-Term Debt	-	-	-	3	62	202
Current Portion of Leases	-	27	26	29	28	30
Current Income Taxes Payable	3	3	6	11	27	15
Current Unearned Revenue	-	-	-	-	5	70
Other Current Liabilities	22	434	540	523	64	123
Total Current Liabilities	25	698	856	892	568	854
Long-Term Debt	546	597	599	621	644	638
Long-Term Leases	-	166	197	195	197	219
Long-Term Unearned Revenue	-	12	4	3	-	3
Long-Term Deferred Tax Liabilities	87	101	129	211	165	66
Other Long-Term Liabilities	5,803	1,100	1,144	1,436	1,950	1,830
Total Liabilities	6,469	2,682	2,941	3,370	3,562	3,665
Common Stock	257	257	257	280	305	306
Additional Paid-In Capital	640	640	640	640	640	640
Retained Earnings	4,568	4,595	4,564	5,101	5,890	5,085
Comprehensive Income & Other	-368	-458	-376	-186	1,015	779
Total Common Equity	5,097	5,034	5,085	5,835	7,850	6,810
Minority Interest	3	5	5	7	6	3
Shareholders' Equity	5,100	5,039	5,090	5,842	7,856	6,813
Total Liabilities & Equity	11,569	7,721	8,031	9,212	11,418	10,478
Total Debt	546	790	822	848	931	1,089
Net Cash (Debt)	1,058	531	374	285	973	430
Net Cash Growth	33.42%	41.98%	31.23%	-70.71%	126.28%	16.22%
Net Cash Per Share	0.58	0.29	0.19	0.14	0.45	0.19
Filing Date Shares Outstanding	1,788	1,787	1,782	1,941	2,116	2,126
Total Common Shares Outstanding	1,788	1,787	1,782	1,941	2,116	2,126
Working Capital	6,264	2,321	2,120	2,279	3,490	2,706
Book Value Per Share	2.73	2.70	2.74	2.90	3.61	3.20
Tangible Book Value	3,772	3,619	3,555	4,321	7,250	6,358
Tangible Book Value Per Share	1.99	1.91	1.88	2.12	3.33	2.99
Machinery	-	128	128	120	104	108

Source: S&P Global Market Intelligence. Standard template. Financial Sources.